(Q43237798)

17 November 2017

title

Formulation design and pharmaceutical development of a novel controlled release form of azithromycin for single-dose therapy (English)

1 reference

17 November 2017

0 references

Julian B Lo

1

1 reference

17 November 2017

Leah E Appel

2

1 reference

17 November 2017

Scott M Herbig

3

1 reference

17 November 2017

Scott B McCray

4

1 reference

17 November 2017

Avinash G Thombre

5

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

Drug Development and Industrial Pharmacy

17 November 2017

published in

1 reference

17 November 2017

volume

35

1 reference

17 November 2017

issue

12

1 reference

17 November 2017

page(s)

1522-1529

1 reference

Evolution of a new drug formulation: the rationale for high-dose, short-course therapy with azithromycin

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03639040903037223

Assessment of the feasibility of oral controlled release in an exploratory development setting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639040903037223

Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639040903037223

Single-dose azithromycin microsphere formulation: a novel delivery system for antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639040903037223

Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639040903037223

Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639040903037223

Clinical trial of chemotherapy identified according to chemosensitivity assay for oral cancer patients with unresectable recurrent lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639040903037223

Value of short-course antimicrobial therapy in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639040903037223

Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired Pneumonia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639040903037223

Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639040903037223

Azithromycin extended release: a review of its use in the treatment of acute bacterial sinusitis and community-acquired pneumonia in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639040903037223

Value of short-course antimicrobial therapy in acute bacterial rhinosinusitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639040903037223

Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639040903037223

Acute exacerbation of chronic bronchitis: expanding short-course therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639040903037223

10.3109/03639040903037223

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference